About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1156 record(s)
Req # A-2020-000579
All electronic documents relating to tobacco product seizures and warning letters pertaining to STLTH as referred to by Health Canada in its response to the Inquiry of Ministry of Mr. Davies on January 23, 2020.Organization: Health Canada
November 2020
Req # A-2020-000649
For the Abbreviated New Drug Submission underlying the generic submission containing the medicinal ingredient “Eltrombopag olamine” included on Health Canada’s Generic Submissions Under Review List, provide the proposed Certified Product Information Document - Chemical Entities.Organization: Health Canada
November 2020
Req # A-2020-000466
Adverse Reaction Report (AER) for botulinum toxin. Report number: E2B_03008417.Organization: Health Canada
November 2020
Req # A-2020-000650
For the Abbreviated New Drug Submission underlying the generic submission containing the medicinal ingredient “Eltrombopag olamine” included on Health Canada’s Generic Submissions Under Review List, provide the “Drug Substance - Nomenclature” .Organization: Health Canada
November 2020
Req # A-2020-000652
For the Abbreviated New Drug Submission underlying the generic submission containing the medicinal ingredient “Eltrombopag olamine” included on Health Canada’s Generic Submissions Under Review List, provide the Cover Letter from the manufacturer.Organization: Health Canada
November 2020
Req # A-2020-000653
For the Abbreviated New Drug Submission underlying the generic submission containing the medicinal ingredient “Eltrombopag olamine” included on Health Canada’s Generic Submissions Under Review List, provide the “Summary Product Information”, “Dosage Forms, Composition and Packaging” and “Pharmaceutical Information” sections of the most recent Product Monograph.Organization: Health Canada
November 2020
Req # A-2020-000724
All Adverse Reaction Reports for the Metformin products listed in the Health Canada public advisory dated February 5, 2020 and updated most recently on June 13, 2020 (RA-72287) from January 1, 2015 to August 18, 2020.Organization: Health Canada
November 2020
Req # A-2020-000779
All records related to the National COVID-19 Volunteer Recruitment Campaign that explain how the idea came about, how many volunteers there were by province, how many volunteers each province ended up using, and any analysis around this campaign being proposed and how it went.Organization: Health Canada
November 2020
Req # A-2020-000228
Adverse Reaction Reports (AERs) for OLMETEC / OLMETEC PLUS. Report numbers: E2B_00483640, 000682357.Organization: Health Canada
November 2020
Req # A-2020-000912
All correspondence and documentation relating to changes or reforms to framework or rules governing longterm care homes in Canada, from May 1, 2020 to September 28, 2020.Organization: Health Canada
November 2020